Comorbidities Associated with COPD Affect Outcomes, Require Attention
At the 2023 American Thoracic Society International Conference a symposium focused on common comorbidities seen with COPD, their management, and research needs.
Daily Dose: Weight Management in Primary Care
Your daily dose of clinical news you may have missed.
New Study Highlights Disparities in Diabetes Care between Urban, Rural Patients
New study found that patients living in urban areas were more likely to meet all aspects of key metrics of diabetes care.
Robust RSV Surveillance Data Will be Key to Getting US Clinicians Comfortable with New Adult Vaccine
Immunize.org's Dr Kelly Moore says that without clear surveillance data on RSV, particularly on hospitalizations, clinicians may hesitate to commit office resources to administration.
Daily Dose: FDA Approves Buprenorphine Extended-release Injection for Opioid Use Disorder
Social Media is a Mental Health Hazard for Nation's Youth, Surgeon General Says
The AAFP and other national medical groups endorsed the warning from Surgeon General Murthy that social media is fueling the mental health crisis among young Americans.
Chronic Pain in America: Who is at Greatest Risk?
A recent CDC report showed that approximately 20% of Americans experienced chronic pain in 2021 and certain groups were most vulnerable. Details in our new slideshow.
Are US Seniors Ready for an RSV Vaccine? Consider the Lessons of COVID-19, says Dr Kelly Moore
Low awareness of RSV in adults and misperceptions about the goal of vaccination aren't new challenges, says Kelly Moore, MD, MPH, Immunize.org president and CEO.
Daily Dose: Migraine without Aura Raises Stroke Risk for Women on Combined Hormonal Contraceptives
FDA Approves Rx Nalmefene Nasal Spray to Reverse Opioid Overdose
In a unique pharmacodynamic study, nalmefene demonstrated rapid reversal of respiratory depression from the synthetic opioid remifentanil and sustained duration of action.
GSK Adult RSV Vaccine: Expert Highlights Path to FDA Approval
Medical director of the NFID William Schaffner, MD, discusses the research behind the FDA's decision to approve the first-ever RSV vaccine.
Weight Loss of 15% with Oral Semaglutide 50 mg Equal to SQ Wegovy: Late Stage Clinical Trial
Efficacy of the daily pill met the standard now established by the once-weekly injection of 15% loss of baseline bodyweight in adults with overweight or obesity, says Novo Nordisk.
Daily Dose: Global Deaths from Ischemic Stroke May Reach 5 Million by 2030
Mental Health in Women with Obesity: An Expert Interview
A nationally recognized obesity expert discusses mental health in women with obesity.
Migraine without Aura May Increase Stroke Risk for Women Taking Combined Hormonal Contraceptives
The findings contradict published clinical guidelines that warn against use of estrogen-containing birth control by women who have migraine with aura.
Dupilumab Reduces COPD Exacerbations for Patient with T2 Inflammation in Landmark Phase 3 Trial
Findings of the BOREAS trial of patients with COPD and type 2 inflammation make dupilumab the first biologic to significantly reduce exacerbations by 30% vs placebo.
GSK Adult RSV Vaxx: Public Health Expert Reviews Topics for ACIP Meeting in June
Immunize.org president and CEO Kelly Moore, MD, MHP, describes the holistic view the ACIP will take of the virus, the vaccine, and the overall economics of the immunization.
Daily Dose: Rise in Diabetes-Related Vascular Deaths Linked to Renal Complications
Statin Therapy May be Protective Against Stroke in People with Atrial Fibrillation: New Study
Statin therapy initiated within 1 year of diagnosis of atrial fibrillation reduced the risk of ischemic stroke or systemic embolism by nearly 20%.
Global Deaths from Ischemic Stroke May Reach 5 Million by 2030, According to New Study
Findings also showed that between 1990 and 2019, the global number of ischemic stroke deaths rose from 2 million to 3 million.
